About this post
Source
Author
Date
1:00 PM | December 25, 2012
Language
English
Categories
URL
Citation
Dr. Matt Petroski and colleagues outline a new method to test a tumor’s resistance to an experimental therapy and pinpoint the genetic culprit before testing the drug in patients—providing a new path toward personalized medicine.
Toth JI, Yang L, Dahl R & Petroski MD (2012). A gatekeeper residue for NEDD8-activating enzyme inhibition by MLN4924., Cell reports, 1 (4) 309-16. PMID: 22832224
Tags
Comments
Log in to leave a comment